Medigene AG Net Asset Quality Index
Medigene AG net asset quality index. Medigene AG (MDG1) has a Net Asset Quality Index of 68.2% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €28.81 Million minus total liabilities of €9.15 Million yields net assets of €19.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Medigene AG shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Medigene AG (2006–2023)
Net asset quality index of Medigene AG from 2006 to 2023. This chart shows how Medigene AG's Net Asset Quality Index has evolved across 18 annual periods from 2006 to 2023. As of June 2024, the index stands at 68.2%, representing net assets of €19.66 Million against total assets of €28.81 Million EUR. Check Medigene AG (MDG1) strategic asset index to assess the company's strategic physical and investment asset allocation.
Medigene AG Net Asset Quality Index by Year (2006–2023)
Medigene AG net asset quality index by year from 2006 to 2023. The table below presents the year-by-year Net Asset Quality Index for Medigene AG from 2006 to 2023, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Medigene AG market cap and net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 66.4% | €21.07 Million | €31.72 Million | €10.65 Million | ▼ -5.2 pp |
| 2022 | 71.6% | €37.03 Million | €51.68 Million | €14.65 Million | ▼ -3.7 pp |
| 2021 | 75.4% | €44.82 Million | €59.47 Million | €14.65 Million | ▲ +4.3 pp |
| 2020 | 71.1% | €53.15 Million | €74.75 Million | €21.60 Million | ▼ -3.8 pp |
| 2019 | 74.9% | €81.82 Million | €109.22 Million | €27.39 Million | ▼ -8.0 pp |
| 2018 | 82.9% | €107.42 Million | €129.59 Million | €22.16 Million | ▲ +5.9 pp |
| 2017 | 77.0% | €86.17 Million | €111.94 Million | €25.77 Million | ▲ +6.6 pp |
| 2016 | 70.4% | €78.59 Million | €111.72 Million | €33.12 Million | ▼ -8.9 pp |
| 2015 | 79.3% | €89.99 Million | €113.53 Million | €23.54 Million | ▲ +10.4 pp |
| 2014 | 68.8% | €49.07 Million | €71.28 Million | €22.21 Million | ▼ -0.1 pp |
| 2013 | 68.9% | €36.28 Million | €52.66 Million | €16.38 Million | ▼ -3.3 pp |
| 2012 | 72.2% | €44.22 Million | €61.26 Million | €17.04 Million | ▼ -17.8 pp |
| 2011 | 89.9% | €47.93 Million | €53.29 Million | €5.36 Million | ▲ +19.8 pp |
| 2010 | 70.1% | €40.80 Million | €58.20 Million | €17.40 Million | ▼ -8.8 pp |
| 2009 | 78.9% | €51.87 Million | €65.72 Million | €13.85 Million | ▼ -1.5 pp |
| 2008 | 80.4% | €64.91 Million | €80.75 Million | €15.84 Million | ▼ -9.3 pp |
| 2007 | 89.7% | €103.09 Million | €114.93 Million | €11.84 Million | ▲ +2.3 pp |
| 2006 | 87.4% | €108.51 Million | €124.14 Million | €15.62 Million | — |